Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Assessment of Methods to Analyze MGMT as a Predictive Factor of Response to Temozolomide in Glioblastomas.

NCT01345370 is registered in ClinicalTrials.gov with Center Eugene Marquis as lead sponsor.

NCT NCT01345370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01345370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Assessment of Methods to Analyze MGMT as a Predictive Factor of Response to Temozolomide in Glioblastomas.
Lead sponsor
Center Eugene Marquis
Phase
Observational
Overall status
Completed
Start date
March 31, 2009
Completion date
June 30, 2015
Enrollment
300 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma